Pulmonary Cell News Volume 11.31 | Aug 11 2022

    0
    20








    2022-08-11 | PULCN 11.31


    Pulmonary Cell News by STEMCELL Technologies
    Vol. 11.31 – 11 August, 2022
    TOP STORY

    Club Cells Employ Regeneration Mechanisms During Lung Tumorigenesis

    Researchers employed lineage-tracing mouse models to investigate the cell of origin of Eml4-Alk lung adenocarcinoma, and showed that Club and alveolar type 2 cells gave rise to tumors.
    [Nature Communications]

    Full Article

    An ISSCR 2022 Innovation Showcase Webinar: Reliable In Vitro Culture Solutions for Your Alveolar Research, presented by Dr. Johanna Finn. Click to Watch Now.
    PUBLICATIONSRanked by the impact factor of the journal

    Cadherin-26 Amplifies Airway Epithelial IL-4 Receptor Signaling in Asthma

    In cultured human bronchial epithelial cells, cadherin-26 knockdown inhibited IL-13 induced IL-4Rα and IL-13Rα1 upregulation and suppressed downstream Jak1 and Stat6 phosphorylation.
    [American Journal of Respiratory Cell and Molecular Biology]

    Abstract

    Decreased Humoral Immune Response in the Bronchi of Rapid Decliners with Chronic Obstructive Pulmonary Disease

    Scientists determined the expression of markers of inflammation in COPD patients with rapid functional decline in comparison to slow or no decliners.
    [Respiratory Research]

    Full Article

    Downregulation of Stem-Loop Binding Protein by Nicotine via α7-Nicotinic Acetylcholine Receptor and Its Role in Nicotine-Induced Cell Transformation

    The authors reported that exposure to liquid nicotine or nicotine aerosol generated from e-cigarette induced downregulation of stem-loop binding protein and polyadenylation of canonical histone mRNAs in human bronchial epithelial cells and in mice lungs.
    [Toxicological Sciences]

    Abstract

    The circRERE/miR-144-3p/TLR2/MMP9 Signaling Axis in COPD Pulmonary Monocytes Promotes the EMT of Pulmonary Epithelial Cells

    Using a co-culture system, researchers identified that the TLR2/MMP9 axis in pulmonary monocytes promoted the epithelial mesenchymal transition (EMT) of pulmonary epithelial cells.
    [Biochemical and Biophysical Research Communications]

    Full Article

    All Trans-Retinoic Acid Modulates Hyperoxia-Induced Suppression of NF-kB-Dependent Wnt Signaling in Alveolar A549 Epithelial Cells

    The authors investigated the mechanisms of action of all trans-retinoic acid in human lung epithelial cells exposed to hyperoxia.
    [PLoS One]

    Abstract

    Down-Regulated m6A Reader FTO Destabilizes PHF1 That Triggers Enhanced Stemness Capacity and Tumor Progression in Lung Adenocarcinoma

    Investigators found that human plant homeodomain finger protein 1 (PHF1) was down-regulated in lung adenocarcinoma samples and low PHF1 expressions correlated with unfavorable clinical characteristics.
    [Cell Death Discovery]

    Full Article

    βIII-Tubulin Suppression Enhances the Activity of Amuvatinib To Inhibit Cell Proliferation in C-Met Positive Non-Small Cell Lung Cancer Cells

    Researchers showed that activity of the multi-kinase inhibitor Amuvatinib was enhanced by βIII-tubulin suppression in independent NSCLC cell lines.
    [Cancer Medicine]

    Full Article

    HEG1 as a Novel Potential Biomarker for the Prognosis of Lung Adenocarcinoma

    Heart development protein with EGF-like domains 1 (HEG1) in lung tissues and cell lines of lung adenocarcinoma were significantly downregulated compared to benign pulmonary disease tissues and alveolar epithelial cells.
    [Cancer Medicine]

    Full Article

    Copper(II) Cation and Bathophenanthroline Coordination Enhance Therapeutic Effects of Naringenin Against Lung Tumor Cells

    Scientists investigated the effects of copper (Cu) (II), naringenin, binary Cu(II)-naringenin complex, and the Cu(II)-naringenin containing bathophenanthroline as an auxiliary ligand on adenocarcinoma human alveolar basal epithelial cells (A549 cells) that were used as models for the study of drug therapies against lung cancer.
    [Biometals]

    Abstract

    Identification of Exosomal circRNA CD226 as a Potent Driver of Non-Small Cell Lung Cancer Through miR-1224-3p/High Mobility Group At-Hook 2 Axis

    Researchers unraveled the precise function of circRNA CD226 in NSCLC pathogenesis.
    [Anti-Cancer Drugs]

    Abstract

    Studying COVID-19 with ALI culture
    REVIEWS

    What Has Been Learned by Cytokine Targeting of Asthma?

    The authors summarized experiences with anticytokine biologics to highlight which specific asthma outcomes they affected and how these effects reflected inflammatory pathways modified by biologics and related to pathophysiologic features of asthma.
    [Journal of Allergy and Clinical Immunology]

    Full Article

    Immunotherapeutic Targets in Non-Small Cell Lung Cancer

    Scientists focus on immunotherapeutic targets in NSCLC tumors and discuss how NSCLC tumor microenvironment may influence patients’ response to immunotherapy.
    [Immunology]

    Abstract

    INDUSTRY AND POLICY NEWS

    Verona Pharma Announces Ensifentrine Meets Primary Endpoint in Phase III ENHANCE-2 Trial for COPD

    Verona Pharma plc announced its top-line Phase III ENHANCE-2 (“Ensifentrine as a Novel inHAled Nebulized COPD thErapy”) trial results evaluating nebulized ensifentrine for the maintenance treatment of COPD.
    [Verona Pharma plc]

    Press Release

    AstraZeneca ADC Barrels Forward as Keytruda Combo Data Make Case for Lung Cancer Use

    AstraZeneca and Daiichi Sankyo have delivered more evidence that their TROP2-directed antibody-drug conjugate may have a future in NSCLC, linking the candidate to a roughly 40% overall response rate when used as part of doublet and triplet combination therapies.
    [Fierce Biotech]

    Press Release

    FEATURED EVENT

    5th International Cancer Symposium

    November 2 – 4, 2022
    Lyon, France

    > See All Events

    JOB OPPORTUNITIES

    Senior Investigator – Cancer Research

    NIH National Cancer Institute – Bethesda, Maryland, United States

    Postdoctoral Fellowship – Translational Cardiovascular Medicine

    University of Alberta – Edmonton, Alberta, Canada

    Research Project Coordinator – Biology

    Dalla Lana School of Public Health – Toronto, Ontario, Canada

    Lecturer/Senior Lecturer – Immunomodulation

    King’s College London – London, United Kingdom

    Research Associate Professor – Breast Cancer Metastasis

    Albert Einstein College of Medicine – Bronx, New York, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Pulmonary Cell News Twitter